Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Centre for Commercialization of Regenerative Medicine

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$28M
Portfolio companies 3
Rounds per year 0.23
Lead investments 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Developer Platform

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Centre for Commercialization of Regenerative Medicine:
Typical Co-investors
Centre for Commercialization of Regenerative Medicine is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Centre for Commercialization of Regenerative Medicine:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Axis Capital Holdings Limited Bermuda, Hamilton
Baofu China, Shanghai
Bremer Tageszeitungen AG -
Delancey Street Partners Pennsylvania, United States, Wayne
Denso Wave Aichi Prefecture, Chita, Japan
Dutchess Opportunity Fund Boston, Massachusetts, United States
FPIM Boca Raton, Florida, United States
Galvanise Capital England, London, United Kingdom
GFC Consultoria Brazil, São Paulo, Sao Paulo
Goodbye Kansas Game Invest Stockholm, Stockholm County, Sweden
Hornbill Capital Advisers India, Maharashtra, Mumbai
Innoport Germany, Hamburg
Kohlberg Ventures California, Portola Valley, United States
Korea Development Bank Seoul, Seoul-t'ukpyolsi, South Korea
Macquarie Capital Markets Canada Ltd. -
Nova Capital Management England, London, United Kingdom
Port of Amsterdam -
QCP Soteria -
Slamdunk Capital Berlin, Berlin, Germany
Thuasne -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Developer Platform
Health Care
$85M10 Feb 2021 Old Toronto, Ontario, Canada

KisoJi Biotechnology

Biotechnology
12 Oct 2016 Laval, Quebec, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Centre for Commercialization of Regenerative Medicine?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 28M
Rounds per year 0.23
Peak activity year 2018
Lead investments 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Developer Platform
Health Care
$85M10 Feb 2021 Old Toronto, Ontario, Canada

KisoJi Biotechnology

Biotechnology
12 Oct 2016 Laval, Quebec, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: